ADMINISTER OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.5 EUR | 0.00% |
|
0.00% | +3.73% |
| Apr. 22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
| Apr. 11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
Evolution of the average Target Price on Administer Oyj
Price target over the last 5 years
History of analyst recommendation changes
03b630a8b96a5bfa56fc24d9a3e96.PH9O3HIEGo50c2mP459eZUSrqx281SRvflwIYIYBkDc.ayYtmxBrKOA-R1rqj6wRKQb9717skFcoKDhyIety23NuDAKJJD1yykIFPA~de9bca25a0e19dceaa7445598daeee90
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.5
EUR
Average target price
2.75
EUR
Spread / Average Target
+10.00%
High Price Target
3
EUR
Spread / Highest target
+20.00%
Low Price Target
2.5
EUR
Spread / Lowest Target
0.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- ADMIN Stock
- Consensus Administer Oyj
